Comparison of Bone and Total Alkaline Phosphatase and Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Alendronate

By Watts N. B.   Jenkins D. K.   Visor J. M.   Casal D. C.   Geusens P.  

Osteoporosis International, Vol. 12, Iss. 4, 2001-05 ,pp. : 279-288

Springer Publishing Company

Access to resources Recommend Favorite

Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis

By Macdonald H.   Nishiyama K.   Hanley D.   Boyd S.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 357-362

Springer Publishing Company

Access to resources Recommend Favorite

Similar Proportions of Women Lose Bone Mineral Density With Raloxifene or Alendronate Treatment

By Adachi Jonathan D.   Adami Silvano   Kulkarni Pandurang M.   Wong Mayme   Stock John L.  

Journal of Clinical Densitometry, Vol. 8, Iss. 3, 2005-09 ,pp. : 273-277

Humana Press, Inc

Access to resources Recommend Favorite

Comparison of the effects of alendronate sodium and calcitonin on bone–prosthesis osseointegration in osteoporotic rats

By Chen B.-L.   Xie D.-H.   Zheng Z.-M.   Lu W.   Ning C.-Y.   Li Y.-Q.   Li F.-B.   Liao W.-M.  

Osteoporosis International, Vol. 22, Iss. 1, 2011-01 ,pp. : 265-270

Springer Publishing Company

Access to resources Recommend Favorite

New bone formation and trabecular bone microarchitecture of highly porous tantalum compared to titanium implant threads: A pilot canine study

By  

CLINICAL ORAL IMPLANTS RESEARCH, Vol. 29, Iss. 2, 2018-02 ,pp. : 164-174

John Wiley & Sons Inc

Access to resources Recommend Favorite